Pershing Edward reported PVCT

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0001493152-25-025335

Machine-readable

Structured copy

Timestamps

Event (reported)

Nov 26, 2025

Published

Nov 28, 2025

Ingested by INSIDER

Nov 5, 04:30 UTC

Last re-read

Nov 5, 04:30 UTC

Extracted facts

Filer

Pershing Edward

Role

Director, CEO

Transaction

Grant or awardAs filed: “A”

Asset

PROVECTUS BIOPHARMACEUTICALS, INC. — 8% Unsecured Convertible Promissory Note

Ticker

PVCT

Price per share

$0

Execution date (reported)

Nov 26, 2025

Days from execution to publication

2

What this establishes

Pershing Edward filed this Form 4 reporting a grant or award of PVCT on Nov 26, 2025. It became public on Nov 28, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

Director, CEO

Pershing Edwardcik:0001689739

Issuer

PROVECTUS BIOPHARMACEUTICALS, INC.cik:0000315545

Revision history · 0

No field has changed since this record was first ingested.